Displaying 9151 - 9200 of 14716 results
Released Company Title Industry Topic
15 Nov 2021
17:40 CET
AGEAS Ageas reports on the progress of share buy-back programme 30301010 Life Insurance Other financial transaction
15 Nov 2021
17:40 CET
AGFA-GEVAERT Agfa-Gevaert: Share buyback program – regulated information 50202025 Electronic Equipment: Gauges and Meters Other subject
15 Nov 2021
17:40 CET
AGEAS Rapport d’Ageas sur le programme de rachat d’actions 30301010 Life Insurance Other financial transaction
15 Nov 2021
17:40 CET
AGFA-GEVAERT Agfa-Gevaert: Aandeleninkoopprogramma – gereglementeerde informatie 50202025 Electronic Equipment: Gauges and Meters Other subject
15 Nov 2021
17:40 CET
AGEAS Ageas rapporteert over de inkoop van eigen aandelen 30301010 Life Insurance Other financial transaction
15 Nov 2021
08:57 CET
TITAN CEMENT Programme de rachats d'actions 50101030 Cement Other subject
15 Nov 2021
08:56 CET
TITAN CEMENT Share buyback programme 50101030 Cement Other subject
15 Nov 2021
08:00 CET
KBC KBC Group: 15 November 2021 – information regarding the traditional annual capital increase reserved for staff 30101010 Banks Other subject
15 Nov 2021
08:00 CET
KBC KBC Groep: 15 november 2021 – informatie m.b.t. traditionele jaarlijkse kapitaalverhoging voor het personeel 30101010 Banks Other subject
15 Nov 2021
07:45 CET
KBC KBC Groupe: KBC acquiert les opérations bulgares de Raiffeisen Bank International 30101010 Banks Mergers, Acquiqitions, Transferts
15 Nov 2021
07:45 CET
KBC KBC Groep: KBC neemt de Bulgaarse activiteiten van Raiffeisen Bank International over 30101010 Banks Mergers, Acquiqitions, Transferts
15 Nov 2021
07:45 CET
KBC KBC Group: KBC acquires Bulgarian operations of Raiffeisen Bank International 30101010 Banks Mergers, Acquiqitions, Transferts
15 Nov 2021
07:00 CET
HYLORIS Hyloris Announces Earlier than Expected PDUFA Date for Maxigesic® IV 20103010 Biotechnology Other subject
15 Nov 2021
07:00 CET
VGP VGP NV: Voting Rights and Denominator 35101010 Real Estate Holding and Development Other subject
15 Nov 2021
07:00 CET
HYLORIS Hyloris annonce la date PDUFA plus tôt que prévue pour Maxigesic® IV 20103010 Biotechnology Other subject
15 Nov 2021
07:00 CET
VGP VGP NV: Stemrechten en Noemer 35101010 Real Estate Holding and Development Other subject
12 Nov 2021
22:30 CET
NYXOAH SA Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference 20102010 Medical Equipment Other subject
12 Nov 2021
22:30 CET
NYXOAH SA Nyxoah Annonce sa Participation à la Piper Sandler 33rd Annual Virtual Healthcare Conference 20102010 Medical Equipment Other subject
12 Nov 2021
18:17 CET
CRESCENT GEREGLEMENTEERDE INFORMATIE - Openbaarmaking over een transparantiekennisgeving (artikel 14, eerste lid, van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen)   15101010 Telecommunications Equipment Other subject
12 Nov 2021
18:16 CET
CRESCENT REGULATED INFORMATION - Disclosure of a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major holdings) 15101010 Telecommunications Equipment Other subject
12 Nov 2021
13:00 CET
CELYAD ONCOLOGY Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting 20103010 Biotechnology Other subject
12 Nov 2021
13:00 CET
CELYAD ONCOLOGY Celyad Oncology présente des données précliniques sur le programme de thérapie allogénique CAR T et précise le concept de l'essai clinique KEYNOTE-B79 lors de la 36e réunion annuelle de la Society for Immunotherapy of Cancer (SITC) 20103010 Biotechnology Other subject
12 Nov 2021
08:00 CET
TEXAF Texaf : INFORMATION TRIMESTRIELLE 35101010 Real Estate Holding and Development Other subject
12 Nov 2021
08:00 CET
TEXAF Texaf: KWARTAALINFORMATIE 35101010 Real Estate Holding and Development Other subject
12 Nov 2021
08:00 CET
TEXAF Texaf: INTERIM STATEMENT 35101010 Real Estate Holding and Development Other subject
12 Nov 2021
07:00 CET
KBC KBC Groep: Resultaat derde kwartaal van 601 miljoen euro 30101010 Banks Commercial results
12 Nov 2021
07:00 CET
KBC KBC Group: Third-quarter result of 601 million euros 30101010 Banks Commercial results
12 Nov 2021
07:00 CET
KBC KBC Groupe: Bénéfice de 601 millions d'euros au troisième trimestre 30101010 Banks Commercial results
11 Nov 2021
08:38 CET
TITAN CEMENT Résultats des neuf premiers mois 2021 50101030 Cement Commercial results
11 Nov 2021
08:37 CET
TITAN CEMENT Nine Month 2021 Results 50101030 Cement Commercial results
11 Nov 2021
08:23 CET
EXMAR ord. Exmar Update liquiditeitspositie 50206030 Marine Transportation Corporate life
11 Nov 2021
08:21 CET
EXMAR ord. Exmar Update Liquidity Position 50206030 Marine Transportation Corporate life
10 Nov 2021
22:05 CET
CELYAD ONCOLOGY Celyad Oncology Announces Third Quarter 2021 Financial Results and Recent Business Highlights 20103010 Biotechnology Other subject
10 Nov 2021
22:05 CET
CELYAD ONCOLOGY Celyad Oncology publie ses résultats financiers du troisième trimestre 2021 et les avancées récentes des activités de la Société 20103010 Biotechnology Other subject
10 Nov 2021
17:21 CET
HYBRID SOFTWARE GROUP PLC Hybrid Software Group PLC: Notification of transactions in shares by persons discharging managerial responsibility 10101015 Software Other subject
10 Nov 2021
07:30 CET
AGEAS Ageas publie ses résultats pour les 9 premiers mois de 2021 30301010 Life Insurance Other financial transaction
10 Nov 2021
07:30 CET
AGEAS Ageas rapporteert resultaten voor de eerste negen maanden van 2021 30301010 Life Insurance Other financial transaction
10 Nov 2021
07:30 CET
AGEAS Ageas reports on its nine month results 2021 30301010 Life Insurance Other financial transaction
10 Nov 2021
07:30 CET
AEDIFICA Aedifica NV/SA: Interim statement from the Board of Directors – 3rd quarter 2021 35102010 Health Care REITs Commercial results
10 Nov 2021
07:00 CET
ARGENX SE argenx to Present at Upcoming Investor Conferences 20103010 Biotechnology Other subject
10 Nov 2021
07:00 CET
BIOCARTIS Press release Biocartis Group NV: Biocartis Q3 2021 Business Update 20101025 Health Services Commercial results
10 Nov 2021
07:00 CET
HYLORIS Hyloris Broadens Pipeline with Novel Patented Combination Product Candidate in Acute Myeloid Leukaemia and Small Cell Lung Cancer 20103010 Biotechnology Other subject
10 Nov 2021
07:00 CET
BIOCARTIS Persbericht Biocartis Group NV: Biocartis Q3 2021 Business Update 20101025 Health Services Commercial results
10 Nov 2021
07:00 CET
HYLORIS Hyloris élargit son portefeuille avec une nouvelle combinaison brevetée de produit candidat dans la leucémie myéloïde aiguë et le cancer du poumon à petites cellules 20103010 Biotechnology Other subject
09 Nov 2021
22:30 CET
NYRSTAR Nyrstar NV –    Court revokes the appointment of experts and halts expert investigation 55102050 Nonferrous Metals Other subject
09 Nov 2021
22:30 CET
NYRSTAR Nyrstar NV –  Rechtbank vernietigt de aanstelling van deskundigen en zet deskundigenonderzoek stop 55102050 Nonferrous Metals Other subject
09 Nov 2021
18:14 CET
BPOST bpost: Third quarter 2021 results 50206040 Delivery Services Legal
09 Nov 2021
18:00 CET
CARE PROPERTY INVEST Publicatie van een transparantiekennisgeving 35102040 Residential REITs Legal
09 Nov 2021
18:00 CET
CARE PROPERTY INVEST Publication of a transparency notification  35102040 Residential REITs Legal
09 Nov 2021
17:58 CET
BPOST bpost: Third quarter 2021 results 50206040 Delivery Services Legal